Answers are grounded in this paper and cite their sources.
The first report of modification of strontium hexaferrite NPs with azacrown ligands for combined radiopharmaceuticals
No takes yet. Share an insight, caveat, or question.
Khabirova et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: